Journey Medical Corp (DERM) has 110 open-market insider trades by 29 insiders since 2014. The most active filer is Thomas G. Wiggans, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Lilly & Co Eli | 10% Owner | — | 1 | $1.5B | 2020-02-20 |
| Thomas G. Wiggans | CEOChairman | — | 29 | $6.7M | 2020-02-20 |
| Andrew Guggenhime | COOCFO | — | 7 | $2.3M | 2020-02-20 |
| Eugene A. Bauer | — | — | 20 | $2.1M | 2020-02-20 |
| Claude Maraoui | CEOPres | — | 8 | $1.9M | 2026-04-22 |
| Fred B. Craves | Dir10% Owner | — | 2 | $1.8M | 2020-02-20 |
| Patrick J. Kerins | 10% | — | 1 | $1.1M | 2014-10-08 |
| Scott D. Sandell | 10% | — | 1 | $1.1M | 2014-10-08 |
| David M. Mott | 10% | — | 1 | $1.1M | 2014-10-08 |
| Forest Baskett | 10% | — | 1 | $1.1M | 2014-10-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ramsey Alloush | COO | Sell | $20K | 2025-05-02 |
| Joseph Benesch | CFO | Sell | $16K | 2025-05-02 |
| Claude Maraoui | President | Sell | $33K | 2025-05-02 |
| Claude Maraoui | CEO & President | Sell | $494K | 2025-03-11 |
| Claude Maraoui | CEO & President | Sell | $407K | 2025-03-06 |
| Claude Maraoui | CEO & President | Sell | $722K | 2025-03-03 |
Companies that share insiders with DERM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Joseph Benesch | CFO | Sell | $7K | 2025-02-21 |
| Joseph Benesch | CFO | Sell | $102K | 2024-08-01 |
| Joseph Benesch | CFO | Sell | $22K | 2024-07-23 |
| Lindsay A. Rosenwald M.D. | Director | Buy | $30K | 2024-03-25 |
| Justin Adam Smith | Director | Buy | $104K | 2024-03-22 |
| Lindsay A. Rosenwald M.D. | Director | Buy | $68K | 2024-03-22 |
| Claude Maraoui | President | Buy | $35K | 2024-03-22 |
| Joseph Benesch | Interim CFO | Sell | $9K | 2024-02-22 |
| Jeffrey Paley | Director | Sell | $9K | 2023-11-28 |